多能干细胞：最新进展与新兴趋势
Pluripotent Stem Cells: Recent Advances and Emerging Trends.
作者信息
Wang Aline Yen Ling, Aviña Ana Elena, Liu Yen-Yu, Kao Huang-Kai
机构信息
Center for Vascularized Composite Allotransplantation, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
出版信息
Biomedicines. 2025 Mar 21;13(4):765. doi: 10.3390/biomedicines13040765.
Abstract
The field of induced pluripotent stem cells (iPSCs) continues to evolve, offering unprecedented potential for regenerative medicine, disease modeling, and therapeutic applications [...].
摘要
诱导多能干细胞（iPSC）领域不断发展，为再生医学、疾病建模和治疗应用带来了前所未有的潜力[...]。
相似文献
1
Pluripotent Stem Cells: Recent Advances and Emerging Trends.多能干细胞：最新进展与新兴趋势
Biomedicines. 2025 Mar 21;13(4):765. doi: 10.3390/biomedicines13040765.
2
Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.利用尿液来源的诱导多能干细胞推进细胞治疗、疾病建模和药物测试中的精准医学。
J Biomed Sci. 2024 May 9;31(1):47. doi: 10.1186/s12929-024-01035-4.
3
Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.干细胞：人类心脏疾病建模和再生医学的变革者。
Int J Mol Sci. 2019 Nov 16;20(22):5760. doi: 10.3390/ijms20225760.
4
Induced pluripotent stem cells and personalized medicine: current progress and future perspectives.诱导多能干细胞与个性化医疗：当前进展与未来展望。
Anat Cell Biol. 2011 Dec;44(4):245-55. doi: 10.5115/acb.2011.44.4.245. Epub 2011 Dec 30.
5
Recent technological updates and clinical applications of induced pluripotent stem cells.诱导多能干细胞的最新技术进展与临床应用
Korean J Intern Med. 2014 Sep;29(5):547-57. doi: 10.3904/kjim.2014.29.5.547. Epub 2014 Aug 28.
6
Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.诱导多能干细胞在心血管疾病建模和精准医学中的应用：美国心脏协会科学声明。
Circ Genom Precis Med. 2018 Jan;11(1):e000043. doi: 10.1161/HCG.0000000000000043. Epub 2018 Jan 12.
7
Induced Mesenchymal Stem Cells: An Emerging Source for Regenerative Medicine Applications.诱导间充质干细胞：再生医学应用的新兴来源。
J Clin Med. 2025 Mar 18;14(6):2053. doi: 10.3390/jcm14062053.
8
Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace.再生医学的新兴趋势：CiteSpace 中的科学计量分析。
Expert Opin Biol Ther. 2012 May;12(5):593-608. doi: 10.1517/14712598.2012.674507. Epub 2012 Mar 25.
9
The march of pluripotent stem cells in cardiovascular regenerative medicine.多能干细胞在心血管再生医学中的进展。
Stem Cell Res Ther. 2018 Jul 27;9(1):201. doi: 10.1186/s13287-018-0947-5.
10
[Induced pluripotent stem cell technology and its application in disease research].[诱导多能干细胞技术及其在疾病研究中的应用]
Yi Chuan. 2020 Nov 20;42(11):1042-1061. doi: 10.16288/j.yczz.20-235.
本文引用的文献
1
Immune Evasion in Stem Cell-Based Diabetes Therapy-Current Strategies and Their Application in Clinical Trials.基于干细胞的糖尿病治疗中的免疫逃逸——当前策略及其在临床试验中的应用
Biomedicines. 2025 Feb 6;13(2):383. doi: 10.3390/biomedicines13020383.
2
Timing and Graded BMP Signalling Determines Fate of Neural Crest and Ectodermal Placode Derivatives from Pluripotent Stem Cells.时间和分级BMP信号决定多能干细胞来源的神经嵴和外胚层基板衍生物的命运。
Biomedicines. 2024 Oct 4;12(10):2262. doi: 10.3390/biomedicines12102262.
3
Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine.类器官：在疾病模型、药物发现、精准医学和再生医学中的发展与应用。
MedComm (2020). 2024 Sep 21;5(10):e735. doi: 10.1002/mco2.735. eCollection 2024 Oct.
4
iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects.诱导多能干细胞衍生的心肌细胞作为疾病模型用于理解先天性心脏缺陷的生物学。
Cells. 2024 Aug 26;13(17):1430. doi: 10.3390/cells13171430.
5
TGF-β modulates cell fate in human ES cell-derived foregut endoderm by inhibiting Wnt and BMP signaling.TGF-β 通过抑制 Wnt 和 BMP 信号来调节人胚胎干细胞源性前肠内胚层的细胞命运。
Stem Cell Reports. 2024 Jul 9;19(7):973-992. doi: 10.1016/j.stemcr.2024.05.010. Epub 2024 Jun 27.
6
Neuronal Cell Differentiation of iPSCs for the Clinical Treatment of Neurological Diseases.用于神经疾病临床治疗的诱导多能干细胞的神经元细胞分化
Biomedicines. 2024 Jun 18;12(6):1350. doi: 10.3390/biomedicines12061350.
7
Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases.诱导多能干细胞和 CRISPR-Cas9 创新技术治疗 α-1 抗胰蛋白酶缺乏症和糖原贮积病。
Cells. 2024 Jun 18;13(12):1052. doi: 10.3390/cells13121052.
8
Detection of ER Stress in iPSC-Derived Neurons Carrying the p.N370S Mutation in the Gene.检测携带该基因p.N370S突变的诱导多能干细胞衍生神经元中的内质网应激
Biomedicines. 2024 Mar 27;12(4):744. doi: 10.3390/biomedicines12040744.
9
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.诱导多能干细胞（iPSCs）：诱导的分子机制与应用。
Signal Transduct Target Ther. 2024 Apr 26;9(1):112. doi: 10.1038/s41392-024-01809-0.
10
CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy.CRISPR/Cas9介导的过继性T细胞疗法定制策略
Pharmaceutics. 2024 Mar 1;16(3):346. doi: 10.3390/pharmaceutics16030346.
Zotero 插件